15-20-2　ⓔ文献

  1. 日本産科婦人科学会・日本病理学会編：子宮体癌取扱い規約 病理編 第4版，金原出版，2017．

  2. Hori M, Matsuda T, et al: Japan Cancer Surveillance Research Group: Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol, 2015; 45: 884–891.

  3. Nomura H, Aoki D, et al: Japanese Gynecologic Oncology Group; Effect of taxane plus platinum regimens vs doxorubicin plus cisplatin as adjuvant chemotherapy for endometrial cancer at a high risk of progression: a randomized clinical trial. JAMA Oncol, 2019; 5: 833–840.

  4. Johnson N, Cornes P: Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev, 2011; 5: CD003175.

  5. 日本婦人科腫瘍学会編：子宮体がん治療ガイドライン2018年版，金原出版，2018．

  6. 榎本隆之：婦人科腫瘍委員会報告 第60回治療年報．日本産科婦人科学会雑誌，2015; 67: 1189–1257.